These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 16937230
21. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. Okamoto K, Mimura K, Murawaki Y, Yuasa I. J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221 [Abstract] [Full Text] [Related]
23. Genetic variations in the matrix metalloproteinase-1 promoter and risk of susceptibility and/or severity of chronic periodontitis in the Czech population. Hollá LI, Jurajda M, Fassmann A, Dvorakova N, Znojil V, Vacha J. J Clin Periodontol; 2004 Aug; 31(8):685-90. PubMed ID: 15257748 [Abstract] [Full Text] [Related]
24. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Köppel H, Leithner A, Wascher TC, Paulweber B, Samonigg H. Clin Cancer Res; 2004 May 15; 10(10):3518-20. PubMed ID: 15161710 [Abstract] [Full Text] [Related]
25. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma]. Lu ZQ, Wang YM, Cao YY, Zhang QJ, Zhang XH, Li YH, Wang HS, Xie HL, Jiao BH, Zhang JH. Ai Zheng; 2007 May 15; 26(5):463-8. PubMed ID: 17672933 [Abstract] [Full Text] [Related]
26. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population. Román-García P, Coto E, Reguero JR, Cannata-Andía JB, Lozano I, Avanzas P, Morís C, Rodríguez I. Coron Artery Dis; 2009 Sep 15; 20(6):383-6. PubMed ID: 19620856 [Abstract] [Full Text] [Related]
27. Association of matrix metalloproteinase-1 promoter polymorphism with generalized aggressive periodontitis in a Chinese population. Cao Z, Li C, Jin L, Corbet EF. J Periodontal Res; 2005 Dec 15; 40(6):427-31. PubMed ID: 16302919 [Abstract] [Full Text] [Related]
28. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population. Takemura N, Yoshida S, Kennedy S, Deguchi M, Ohara N, Maruo T. J Soc Gynecol Investig; 2006 Apr 15; 13(3):232-6. PubMed ID: 16638593 [Abstract] [Full Text] [Related]
29. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. Li Y, Jin X, Kang S, Wang Y, Du H, Zhang J, Guo W, Wang N, Fang S. Gynecol Oncol; 2006 Apr 15; 101(1):92-6. PubMed ID: 16278009 [Abstract] [Full Text] [Related]
30. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer. Szyllo K, Smolarz B, Romanowicz-Makowska H, Niewiadomski M, Kozlowska E, Kulig A. J Exp Clin Cancer Res; 2002 Sep 15; 21(3):357-61. PubMed ID: 12385578 [Abstract] [Full Text] [Related]
32. Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis. Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG. Scand J Rheumatol; 2003 Sep 15; 32(4):235-9. PubMed ID: 14626631 [Abstract] [Full Text] [Related]
33. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma. Hashimoto T, Uchida K, Okayama N, Imate Y, Suehiro Y, Hamanaka Y, Ueyama Y, Shinozaki F, Yamashita H, Hinoda Y. Cancer Lett; 2004 Jul 28; 211(1):19-24. PubMed ID: 15194213 [Abstract] [Full Text] [Related]
34. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population. Albayrak S, Cangüven O, Göktaş C, Aydemir H, Köksal V. Urol Int; 2007 Jul 28; 79(4):312-5. PubMed ID: 18025848 [Abstract] [Full Text] [Related]
36. An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer. Przybylowska K, Zielinska J, Zadrozny M, Krawczyk T, Kulig A, Wozniak P, Rykala J, Kolacinska A, Morawiec Z, Drzewoski J, Blasiak J. J Exp Clin Cancer Res; 2004 Mar 28; 23(1):121-5. PubMed ID: 15149160 [Abstract] [Full Text] [Related]
38. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer. Vairaktaris E, Yapijakis C, Vasiliou S, Derka S, Nkenke E, Serefoglou Z, Vorris E, Vylliotis A, Ragos V, Neukam FW, Patsouris E. Anticancer Res; 2007 Mar 28; 27(6B):4095-100. PubMed ID: 18225577 [Abstract] [Full Text] [Related]
39. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM, IBSEN Study Group. J Hepatol; 2004 Aug 28; 41(2):209-14. PubMed ID: 15288468 [Abstract] [Full Text] [Related]
40. The association of the metalloproteinase-3 gene promoter polymorphisms and the middle cerebral artery stenosis. Fu C, Xing Y, Song X. Cell Biochem Biophys; 2011 Apr 28; 59(3):185-9. PubMed ID: 21113741 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]